Idiopathic intracranial hypertension. A prospective study of 50 patients
- PMID: 1998880
Idiopathic intracranial hypertension. A prospective study of 50 patients
Abstract
Management of patients with idiopathic intracranial hypertension (IIH) should be based on the presence and progression of visual loss. To characterize the clinical course of IIH more completely, we monitored the clinical status, especially visual function, in 50 consecutive newly-diagnosed patients over a period of 2 to 39 months (average follow-up 12.4 months). The mean age at onset of symptoms was 31 (range 11-58) yrs; 46 (92%) were women and 47 (94%) were obese (mean weight 90 kg). Common symptoms were headache (92%), transient visual obscurations (72%) and intracranial noises (60%); 13 of the patients (26%) initially had complaints of sustained visual loss. There was visual loss as determined by Goldmann perimetry in 96% and by automated perimetry in 92%. Contrast sensitivity testing was abnormal in 50% and Snellen acuity in 22%. Two patients (4%) became blind in both eyes. The Goldmann visual field grade improved in 60% of patients but visual function deteriorated in 5 (10%). Deterioration of visual field grade was significantly associated only with weight gain during the year before diagnosis. Visual loss in patients with IIH is common and is often reversible. Patients should be evaluated by perimetry using an appropriate strategy and contrast sensitivity testing, along with careful examination of the optic discs.
Similar articles
-
Assessment of visual function in idiopathic intracranial hypertension: a prospective study.Eye (Lond). 1998;12 ( Pt 1):111-8. doi: 10.1038/eye.1998.18. Eye (Lond). 1998. PMID: 9614526 Clinical Trial.
-
Functional visual loss in idiopathic intracranial hypertension.Ophthalmology. 2009 Sep;116(9):1808-1813.e1. doi: 10.1016/j.ophtha.2009.03.056. Epub 2009 Jul 30. Ophthalmology. 2009. PMID: 19643491
-
Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function.Invest Ophthalmol Vis Sci. 1998 Jan;39(1):134-42. Invest Ophthalmol Vis Sci. 1998. PMID: 9430554
-
Idiopathic intracranial hypertension.Neurol Clin. 1991 Feb;9(1):73-95. Neurol Clin. 1991. PMID: 2011112 Review.
-
[Idiopathic intracranial hypertension and organ of vision].Klin Oczna. 2012;114(2):153-5. Klin Oczna. 2012. PMID: 23346807 Review. Polish.
Cited by
-
Clinical and demographic differences between idiopathic intracranial hypertension patients with mild and severe papilledema.Taiwan J Ophthalmol. 2020 Oct 7;11(1):53-56. doi: 10.4103/tjo.tjo_44_20. eCollection 2021 Jan-Mar. Taiwan J Ophthalmol. 2020. PMID: 33767955 Free PMC article.
-
An update on idiopathic intracranial hypertension.Rev Neurol Dis. 2010 Spring-Summer;7(2-3):e56-68. Rev Neurol Dis. 2010. PMID: 20944524 Free PMC article. Review.
-
Idiopathic intracranial hypertension (pseudotumor cerebri).Curr Neurol Neurosci Rep. 2008 Mar;8(2):87-93. Curr Neurol Neurosci Rep. 2008. PMID: 18460275 Review.
-
The role of optical coherence tomography in therapeutics and conditions, which primarily have systemic manifestations: a narrative review.Ther Adv Ophthalmol. 2019 Mar 22;11:2515841419831155. doi: 10.1177/2515841419831155. eCollection 2019 Jan-Dec. Ther Adv Ophthalmol. 2019. PMID: 30923793 Free PMC article. Review.
-
Cranial morcellation decompression for refractory idiopathic intracranial hypertension in children.Childs Nerv Syst. 2018 Jun;34(6):1111-1117. doi: 10.1007/s00381-018-3766-1. Epub 2018 Mar 3. Childs Nerv Syst. 2018. PMID: 29502207